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MUSCARINIC ANTIBODIES AND HEART RATE RESPONSES TO DYNAMIC EXERCISE AND TO THE 
VALSALVA MANEUVER IN CHRONIC CHAGASIC PATIENTS
Barbara C. DAS NEVES(1), Mey Lyn BACILIO(1), Lisbeth BERRUETA(2), Siham SALMEN(2), Darrell L. PETERSON(3),  
Jose H. DONIS(1), Tulio J. NUÑEZ(1) & Diego F. DAVILA(1) 
SUMMARY
We have studied the cardiac chronotropic responses to the Valsalva maneuver and to dynamic exercise of twenty chronic chagasic 
patients with normal left ventricular function and no segmental wall abnormalities by two-dimensional echocardiogram. The absolute 
increase in heart rate of the patients (∆ = 21.5 ± 10 bpm, M±SD) during the maneuver was significantly diminished when compared to 
controls (∆ = 31.30 ± 70, M±SD, p = 0.03). The minimum heart rate (58.24 ± 8.90 vs. 62.80 ± 10, p = 0.68) and the absolute decrease 
in heart rate at the end of the maneuver (∆ = 38.30 ± 13 vs. ∆ = 31.47 ± 17, p = 0.10) were not different from controls. The initial heart 
rate acceleration during dynamic exercise (∆ = 12 ± 7.55 vs. ∆ = 19 ± 7.27, M±SD, p = 0.01) was also diminished, but the heart rate 
recovery during the first ten seconds was more prominent in the sero-positive patients (Median: 14, Interquartile range: (9.75-17.50 
vs. 5(0-8.75, p = 0.001). The serum levels of muscarinic cardiac auto-antibodies were significantly higher in the chagasic patients 
(Median: 34.58, Interquartile Range: 17-46.5, Optical Density) than in controls (Median: 0, Interquartile Range: 0-22.25, p = 0.001) 
and correlated significantly and directly (r = 0.68, p = 0.002) with early heart rate recovery during dynamic exercise. The results of 
this investigation indirectly suggest that, the cardiac muscarinic auto-antibodies may have positive agonist effects on parasympathetic 
heart rate control of chagasic patients. 
KEYWORDS: Chagas disease; Muscarinic receptors; Cardiac muscarinic auto-antibodies; Parasympathetic; Dynamic exercise; 
Valsalva Maneuver.
INTRODUCTION
The natural history of Chagas’ disease is characterized by an acute and 
chronic phase. The latter includes an indeterminate and a cardiac form31. 
Although the responsible mechanisms are yet to be determined, Chagas 
heart disease appears to evolve from localized myocardial damage to a 
clinical form of congestive cardiomyopathy with extensive myocardial 
damage10,13,39. A cardiac autoimmune response, aimed at the cardiac 
muscarinic receptors, and several other hypotheses have been postulated 
in order to explain the progression of myocardial damage4,28,29,33,34,36.
A cardiac autoimmune response arises in chagasic patients because of 
antigenic mimicry between the parasite and cardiac muscarinic receptors32. 
The second extracellular (o2) and the third intracellular loops (i3), of 
these receptors, are considered as autoimmune epitopes in patients with 
chronic Chagas’ disease22,40. The autoimmune response occurs early on 
the natural history of the disease and it is considered to be responsible for 
the abnormalities of parasympathetic control of heart rate14,21,23,41-44. These 
investigations have demonstrated that, the chronotropic responses to cardiac 
autonomic tests are apparently impaired in the indeterminate form of the 
disease. However, we7-9,20,21,37 and other investigators16 have found that 
chagasic patients who are in different stages of natural history of the disease 
may have normal, abnormal2 or even enhanced responses to conventional 
cardiac autonomic tests15,27. Moreover, the frequency and time domain 
indexes of parasympathetic modulation may be suppressed in the supine 
position, but become similar to controls in the standing position and while 
performing isometric exercise6,24,27,45. Since, muscarinic auto-antibodies 
may behave as positive allosteric modulators of parasympathetic activity25; 
a diminished high frequency component of heart rate variability41 and the 
presence of a slow heart rate44 could be an indirect expression of the agonist 
effect. Thus, an alternative explanation for the “impaired” chronotropic 
response to the cardiac autonomic tests would be over stimulation with 
saturation of the parasympathetic system3,11,12,42. Indeed, as stated by 
BENCHIMOL-BARBOSA a continuous cholinergic effect of anti-M2 
antibody, by acting on the muscarinic receptor of the sinus node cells, could 
slow heart rate and limit acute heart rate variations. Therefore, adjustments 
of heart rate in response parasympathetic efferent activity are expected 
to be apparently “impaired”3. Consequently, we have studied the cardiac 
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chronotropic responses to the Valsalva maneuver and to dynamic exercise and 
correlated them with the serum levels of cardiac muscarinic auto-antibodies, 
of chagasic patients who were in the indeterminate form of the disease.
METHODS
We studied twenty asymptomatic patients with at least two positive 
serologic tests for Chagas’ disease. The tests used for the serologic 
diagnosis of Chagas disease were: 1. Test ELISA Chagas III. Grupobios 
S.A. (Santiago de Chile). 2. CruziElisa. Diagnostico y Genetica (Diagen), 
(Mérida, Venezuela) 3. Chagas AB Rapid. Standard Diagnostics, Inc. 
(Yongin-si, Korea). All patients had clinical examinations, surface EKG’s, 
Chest x-rays and two-dimensional echocardiograms. Patients came from 
western Venezuela (States of Mérida, Táchira and Zulia). They had no 
other co-morbidities (i.e., Cardiac, Pulmonary or Metabolic diseases) and 
none of them were receiving other medication. Eighteen sero-negative 
subjects from the same geographical area and matched by age and EKG 
abnormalities, were included as a control group. On the day of the study, 
patients were in the post absorptive state and had not ingested coffee or 
smoked cigarettes for the last 12-24 hours. All procedures and blood tests 
were performed in the same environment (room temperature 20-24 °C) 
and at the same time of the day. The Valsalva maneuver and the dynamic 
exercise test were performed on separate days. Patients and sero-negative 
individuals were informed about the purpose of the investigation and signed 
an informed consent. This protocol was approved by the Commission for 
Clinical Investigations of the Instituto de Investigaciones Cardiovasculares 
of the University of Los Andes in Mérida, Venezuela.
Valsalva maneuver protocol: All patients practiced the maneuver 
in the sitting position two or three times in order to become familiar with 
it. Following a normal intake of breath, patients were instructed to blow 
into a handmade mouth piece connected to a mercury manometer and 
maintain a pressure of 40 mm Hg for 20 seconds. Lead II of the surface 
EKG was used to continuously record the heart rate changes prior to, 
during and after recovery from the maneuver. The following criteria 
were used to assess the validity of the maneuver: facial plethora and 
jugular vein distension. The resting heart rate was obtained by averaging 
the R-R intervals during three minutes prior to the definitive maneuver. 
The maximum tachycardia (shortest R-R interval while performing 
the maneuver) and maximum bradycardia (longest R-R interval at the 
end of the maneuver) were used to calculate the Valsalva index. The 
absolute increase in heart rate was obtained by subtracting the shortest 
R-R interval during the maneuver, from the longest R-R interval prior 
to the maneuver. The absolute decrease in heart rate was obtained by 
subtracting the shortest R-R interval during the maneuver, from the 
longest R-R following the maneuver19,26. The data were stored in a hard 
disk and played back for analysis. Data are expressed as beats per minute. 
Dynamic exercise protocol: The heart rate changes during the early 
stages30,35 and recovery phases of dynamic exercise were assessed by 
performing a maximal standard stress test5. Heart rate prior to, during and 
after exercise was stored in a hard disk and played back for analysis. The 
resting heart rate was obtained, in the standing position, by averaging the 
R-R intervals during one minute prior to exercise. The initial heart rate 
acceleration (first 10 seconds) was obtained by subtracting the shortest R-R 
interval, at this moment of exercise, from the longest R-R recorded prior 
to exercise. The heart recovery at 10 seconds, and at one and two minutes 
following exercise, was obtained by subtracting the shortest R-R interval 
at peak exercise (maximum heart rate) from the longest R-R intervals at 10 
seconds, first minute and second minute following cessation of exercise18.
Cloning and expression of loop2 M2 Muscarinic receptor: The loop2 
fragment was obtained by PCR from human cDNA M2 muscarinic receptor 
(MAR 020000020, www.cdna.org.). The following primers were used: 
Forward [5’-GGCCATGGTTCATTGTAGGGGTGAGAACTGTG-3’] 
engineered to contain the NcoI restriction site while retaining the start 
codon, and a reverse primer [5’-CCAAGCTTAAATAGCCGTACCAA
AGGTGACAGC-3’], that was designed to contain a stop codon and the 
HindIII restriction site. Following amplification of the fragment using 
Pfu Turbo DNA polymerase (Stratagene), the amplified fragment was 
digested with NcoI and HindIII and ligated to pET30a. Transformed 
E. coli (BL21) were selected on kanamycin (25 μg/mL) and screened for 
insert and sequenced to verify the correct clone. Both pET30a expression 
vector (Novagen, Inc., Madison, Wis.), which contained an N-terminal 
hexahistidine tag, plus the thrombin sequence followed by loop2 
sequence, and vector alone (only with thrombin sequence), were purified 
and used to transform E. coli BL21-CodonPlus-RIPL, then expanded 
and induced for protein synthesis with 0.5 mM of IPTG over the course 
of three hours, afterwards the proteins were purified using Sepharose 
Ni/nitrilotriacetic acid (NTA) column (BioRad). The presence of 6xHis-
thrombin-loop2 and 6xH-thrombin was monitored by electrophoresis 
and Western blot.
Enzyme-linked immunosorbent assay (ELISA): ELISA was 
performed according to standard protocols. Briefly, 96 flat well bottomed 
polystyrene plates were coated overnight with recombinant proteins 
(thrombin-loop2 and thrombin) previously resuspended at 10 mg/mL 
in carbonate buffer pH 9.6. To avoid background interference, antigen-
coated plates were blocked with PBS containing 1% BSA and 0.1% 
Tween 20. Sera were obtained from 20 chagasic patients and 18 healthy 
individuals. Triplicates from each sample were used in 1:1000 dilution 
in order to improve specificity of the antigen-antibody reaction, and were 
added to the antigen-bound surface and incubated at room temperature for 
one hour. After extensive washing, the plates were subsequently incubated 
for one hour with anti-human IgG horseradish peroxidase-conjugated 
antibodies (1:5,000) (Santa Cruz, Biotechnology, CA) and thoroughly 
washed. The read out of the reaction was achieved by color development 
obtained by incubation with the substrate o-phenylenediamine (Sigma-
Aldrich, St. Louis, MO) and measured at 490 nm in a microplate reader 
(BioTek ELx800; Cole-Parmer). In order to further improve specificity, 
optical densities read out generated from thrombin alone were subtracted 
from the optical density signal generated by His-trom-loop. Absorbance 
values were expressed in milliunits of optical density (mU OD) to 
multiply by 1000 times the absorbance values17. A ROC curve analysis 
will be elaborated using lectures of optical densities for antibodies against 
muscarinic receptors obtained from all analyzed samples vs. serological 
tests for Chagas disease per each patient. 
Statistical methods: Data are expressed as absolute numbers and 
percentages. The one sample Kolmogorov-Smirnov and the Shapiro-Wilk 
tests were used to analyze for an normal or abnormal distribution of the 
data. Continuous normally distributed variables are expressed as mean 
± standard deviation and abnormally distributed variables as median and 
interquartile range (IQRs) (25th and 75th percentiles). Categorical variables 
were compared with chi-square tests or the Fisher exact test. Unpaired 
Student t-test was used for intergroup comparisons of normally distributed 
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variables and the Mann-Whitney test for abnormally distributed variables. 
Correlation analysis of the heart rate responses and muscarinic cardiac 
auto-antibodies of chagasic was performed by Spearman test. Statistical 
significance was considered as p < 0.05. 
RESULTS
Clinical and echocardiographic characteristics: We have studied 
twenty sero-positive patients who were in the indeterminate (n = 13) and 
cardiac (n = 7) stages of Chagas’ disease. Mean age was 46 ± 13.29. Males 
predominated (62.50%). Chest x-rays and surface electrocardiograms 
were normal except for the presence of right bundle branch block, in 35% 
of patients and in 38% of sero-negative controls. Left ventricular function 
and wall motion, as assessed by two dimensional echocardiograms, were 
normal in all sero-positive patients. The serum levels of muscarinic 
cardiac auto-antibodies were significantly higher in the chagasic patients 
(Median: 34.58, IQR 17- 46.50 (mU OD)) as compared to controls 
(Median: 0, IQR 0-22.25 p = 0.001).
A cut-off value of 11 (mU OD) was determined from the Receptor-
Operator-Curve (Serology for Chagas’ disease vs. Serum levels of 
muscarinic auto-antibodies). The area under the curve was 0.768 with 
a sensitivity of 80% (Confidence interval 56-94)) and a specificity of 
72.20% (Confidence intervals 46-90). Thus, five sero-negative subjects 
(27.80%) had serum values above the cut-off value and four sero-positive 
patients (20%) had serum values below the cut-off point (Fig. 1).
Heart rate responses to the Valsalva maneuver: The Valsalva 
maneuver was performed successfully on only seventeen of the twenty 
patients with positive serology. The maximum heart rate achieved during 
the maneuver (89.71 ± 18.40 beats per minute, bpm) and the absolute 
increase in heart rate (∆ = 21.50 ± 10 bpm) were significantly diminished 
in the chagasic patients in comparison to controls (101.10 ± 12.90 bpm, 
∆ = 31.30 ± 70 bpm) (Table 2). However, the minimum heart rate achieved 
following the maneuver (58.24 ± 8.90, bpm) and the absolute decrease in 
heart rate (∆ = 38.30 ± 13 bpm) of the sero-positive patients were similar 
to controls (62.80 ± 10 bpm, ∆ = 31.47 ± 17) (Table 2). The Valsalva 
Index was similar in both groups. 
Heart rate responses to dynamic exercise: Basal heart rates of 
the chagasic patients were not different from those of the controls. The 
initial heart rate acceleration of the chagasic patients (∆ = 12 ± 7.55 bpm) 
was significantly diminished in comparison to controls (19 ± 7.27 bpm, 
Fig. 1 - Receptor operator curve: Serology for Chagas disease vs serum levels of muscarinic 
auto-antibodies. A cut-off value of 11 milliunits of optical density (mU OD) was determined. 
The area under the curve was 0.768 with a sensitivity of 80% (Confidence interval 56-94) and 
a specificity of 72.20% (Blue dotted lines = confidence intervals 46-90).
Table 1
Clinical and echocardiographic characteristics
Variables
Negative 
Serology
(n = 18)
Positive 
Serology
(n = 20)
p value
Age (years)) 42 ± 9.75 46 ± 13.29 NS
Male (%) 50 62.50 NS
Weight (Kg) 71.56 ± 8.85 71.50 ± 9.70 NS
Height (cm) 164.44 ± 9.18 162.88 ± 8.89 NS
Chest-X-Ray    
  CTI < 0.50 (%) 18 20 NS
  CTI > 0.50 (%) 0 0 NS
      EKG   
  Normal (%) 62.00 65.00 NS
  RBBB   (%) 38.00 35.00 NS
Echocardiogram   
  LV mass Index  g/m2 71.70 ± 16.21 83.50 ± 23.4 NS
  LV relative wall thickness 0.41 ± 0.08 0.39 ± 0.03 NS
  Ejection fraction 60.69 ± 4.09 58.56 ± 5.22 NS
  Segmental wall motion
          Normal 18 20 NS
CTI: cardiothoracic  index.  RBBB: right bundle  branch block. LV = Left 
ventricle.  NS = No significance.
Table 2
Heart rate responses during the Valsalva’s  maneuver
Variable
 
Negative 
Serology
(n = 17)
Positive 
Serology
(n = 15)
p value
 
Basal heart rate (bpm) 68.8 ± 9.90 63.65 ± 11.10 NS
Maximum heart rate 101.10 ± 12.90 89.71 ± 18.40 0.05
∆acceleration 31.30 ± 7.00 21.50 ± 10 0.03
Minimun heart rate (bpm) 62.80 ± 10 58.24 ± 8.90 0.68
∆recovery 31.47 ± 17 38.30 ± 13 0.10
Valsalva index 1.63 ± 10.28 1.55 ± 0.32 0.17
Data are expressed as Mean ± Standard deviation (M ± SD).  ∆acceleration  = 
Magnitud of heart rate acceleration during the maneuver.  ∆recovery = Magnitud 
of heart rate recovery following the maneuver. No significance.
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p = 0.01). Heart rate recovery during the first ten seconds of the exercise 
was more prominent in the sero-positive patients (Δ10R
 
= 14 (9.75 - 17.50 
bpm) vs. 5 (0-8.75 bpm, p = 0.001). Heart rate recovery during the first 
and second minutes following exercise as well as duration of exercise 
was similar in both groups (Table 3).
Correlation analysis between the heart rate responses and 
serum levels of cardiac auto-antibodies: Correlation analysis, of the 
heart rate responses and the serum levels of muscarinic auto-antibodies, 
of sero-positive patients showed: 1. that the heart rate responses to the 
Valsalva maneuver did not correlate with the serum levels of muscarinic 
auto-antibodies; 2. that the initial heart rate acceleration during the first 
10 seconds of dynamic exercise did not correlate with the muscarinic 
auto-antibodies (Table 4, Fig. 2A); 3. that the absolute decrease in heart 
rate, following cessation of exercise (first ten seconds), correlated directly 
and significantly with the serum levels of muscarinic auto-antibodies 
(Table 4, Fig. 2B). 
DISCUSSION
Heart rate changes, during the early and late phases of the Valsalva 
maneuver and of dynamic exercise, indirectly reflect modulation of the 
autonomic nervous system on the sinus node. Thus, parasympathetic 
withdrawal is mostly responsible for the heart rate acceleration observed 
during the early phase of the Valsalva maneuver and the first seconds 
of dynamic exercise. Reactivation of parasympathetic activity, on 
the other hand, determines the magnitude of heart rate deceleration 
following termination of the maneuver and immediately after cessation 
of dynamic exercise. These two tests assess the responsiveness of the 
cardiac autonomic nervous system, particularly the negative chronotropic 
effects of the parasympathetic system on heart rate5,19,26,30,35.
Parasympathetic effects on heart rate, of asymptomatic chagasic 
patients who are in the indeterminate and cardiac stages of the 
disease, have been studied under stressful2,20,27, and under steady-state 
conditions6,24,45. The findings of these clinical investigations have been 
conflicting and controversial. Nonetheless, parasympathetic effects 
on heart rate are currently considered, by most investigators, as being 
impaired by cardiac muscarinic auto-antibodies14,21-23,42,43. We have 
postulated, on the contrary, that parasympathetic activity is enhanced 
by the allosteric effects of the muscarinic cardiac auto-antibodies11,12. 
The present clinical investigation included asymptomatic chagasic 
patients, who were in the indeterminate and cardiac forms of the 
disease and had normal two-dimensional echocardiograms. Heart rate 
acceleration, during the early phases of the Valsalva maneuver and of 
dynamic exercise, was significantly diminished in the chagasic patients. 
However, the heart rate changes, during the late phases of the Valsalva 
maneuver and of dynamic exercise, revealed a normal and enhanced 
response respectively. These apparently “discordant” results would 
indirectly suggest that: 1. the diminished initial heart rate acceleration 
during the early phases of both of these tests is indicative of reduced or 
impaired resting parasympathetic activity; 2. the normal or augmented 
heart rate recovery at the end of these two same tests would indicate, 
on the other hand, that parasympathetic reactivation is normal and even 
enhanced. Thus, chronotropic responses to parasympathetic withdrawal 
would be apparently impaired, but the chronotropic responses to 
parasympathetic reactivation are normal or even accentuated. How 
can one reconcile these apparently “discordant” results, with current 
knowledge on cardiac parasympathetic function in chronic chagas heart 
disease?
Muscarinic receptors are known to be up-regulated by Trypanosoma 
cruzi infection and muscarinic cardiac auto-antibodies potentiate the 
chronotropic effects of acetylcholine on the cardiac muscarinic receptors 
of the sinus node25,38. Therefore, the postsynaptic muscarinic receptors, 
which mediate the negative chronotropic effects of parasympathetic 
Table 3
Heart rate responses during dynamic exercise 
Variable
 
Negative 
Serology
(n = 18)
Positive 
Serology
(n = 20)
p value
 
Basal heart rate 
(bpm)
78 ± 11.60 69 ± 7.4 0.31
∆ 10
sI  (bpm) 19 ± 7.27 12 ± 7.55 0.01
Maximum heart 
rate   (bpm)
165.50 (155-179) * 159.50 (150-176) * 0.26
Heart rate recovery    
         Δ10R 5(0 - 8.75)* 14 (9.75-17.50) * 0.001
         ∆1Rmin 30 ± 13.08 32 ± 11.26 0.27
         ∆2Rmin 43 ± 12.12 43 ± 13.5 0.76
Exercise time 
(minutes)
8.2 ± 2.35 7.64 ± 2.32 0.83
Data are expressed as Mean ± Standard deviation (M ± SD).  *Data are expressed 
as Median and interquartile range (25th  and 75th  percentiles). *Mann-Whitney test 
was used for intergroup comparisons.  ∆ 10
sI = Magnitud of initial  heart accelera-
tion during the first 10 seconds. bpm = beats per minute.  Δ10R = Magnitud of heart 
rate recovery during the first 10 seconds post-exercise. ∆1Rmin = Magnitud of 
heart rate recovery during the first minute post-exercise. ∆2Rmin = Magnitud of 
heart  rate recovery during the second minute post-exercise.
Table 4
Correlation analysis between the heart rate responses and serum levels of 
muscarinic auto-antibodies
Variable
Negative Serology Positive Serology
r p value r p value
Valsalva’s  maneuver
   ∆acceleration 0.42 0.11 - 0.09 0.69
   ∆recovery 0.36 0.51 0.18 0.47
Dynamic exercise
   ∆10
sI 0.23 0.31 0.23 0.33
   ∆10R -0.11 0.62 0.68 0.002
Spearmen test was used for correlation analysis. ∆acceleration  = Magnitud of 
heart rate acceleration during the maneuver. ∆recovery = Magnitud of heart rate 
recovery following the maneuver. ∆10
sI = Magnitud of initial heart acceleration 
during the first 10 seconds of dynamic exercise. Δ10R = Magnitud of heart rate 
recovery during the first 10 seconds post-exercise.
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activity, are numerically increased and positively influenced by 
Trypanosoma cruzi infection. In this particular context, we have found 
that the serum levels of the cardiac muscarinic auto-antibodies correlated 
directly with the magnitude of cardiac deceleration, following cessation 
of exercise. Therefore, the more prominent heart rate recovery of the 
chagasic patients could be an expression of a positive allosteric effect 
of the muscarinic auto-antibodies on the membrane muscarinic receptor. 
Alternatively, these results could be due to a direct agonist effect of 
the auto-antibodies on the muscarinic receptor and thereby potentiate 
early heart recovery. Consequently, the results of this investigation, 
although not conclusively demonstrating the presence of saturation of 
the cardiac parasympathetic system, indirectly suggest that the cardiac 
muscarinic auto- antibodies may have a positive agonist action on 
parasympathetically-mediated heart rate recovery, at the cessation of 
dynamic exercise. 
Limitations of the study: The Valsalva maneuver was not 
successfully performed by all the chagasic patients included in this 
investigation. During the maneuver, an aspect such as the maximum 
depth of inspiration before straining is not uniform in all subjects. A 
smaller sample size and methodological aspects of the maneuver may, in 
part, explain the absence of a significant correlation between the serum 
levels of cardiac muscarinic auto-antibodies and the heart rate responses 
to the maneuver. Moreover, the auto-antibodies did not correlate 
with the heart rate acceleration of the early stages of both autonomic 
tests. These limitations definitively argue against our hypothesis of a 
saturation of the cardiac parasympathetic system versus parasympathetic 
dysautonomia. Nonetheless, the results of this investigation clearly show 
that, concerning parasympathetic withdrawal or reactivation-mediated 
heart rate responses, the former can be diminished, but the latter are 
normal or even enhanced. Further studies are needed to clarify the true 
nature of these apparently “discordant” heart rate responses. 
In summary, we have studied the heart rate responses of sero-positive 
patients to the Valsalva maneuver and to dynamic exercise. These heart 
rate responses were apparently depressed during the early phases of 
both autonomic tests, but preserved in the late phases. Particularly, 
the magnitude of early heart rate recovery at the cessation of exercise 
was more prominent in the chagasic patients and correlated directly 
and significantly with the serum levels of the cardiac muscarinic 
auto-antibodies. These results indirectly suggest that the cardiac 
muscarinic auto-antibodies may have positive agonists effects on 
parasympathetically-mediated heart rate recovery of chronic chagasic 
patients.
RESUMO
Anticorpos muscarínicos e resposta da frequência cardíaca ao 
exercício dinâmico e a manobra de Valsalva na doença de Chagas 
crônica
Foram estudadas as respostas cronotrópicas cardíacas à manobra 
de Valsalva e ao exercício dinâmico de vinte pacientes chagásicos com 
função ventricular esquerda normal e sem alterações da contractilidade 
segmentar por ecocardiografia bidimensional. O aumento absoluto 
da frequência cardíaca dos pacientes (Δ = 21,5 ± 10 bpm, M ± DP) 
durante a manobra de Valsalva foi significativamente menor quando se 
comparava ao grupo controle (Δ = 31,30 ± 70, p = 0,03). A frequência 
cardíaca mínima (58,24 ± 8,90 vs 62,80 ± 10, p = 0,68) e a diminuição 
da frequência cardíaca absoluta no final da manobra (Δ = 38,30 ± 13 
vs Δ = 31,47 ± 17, p = 0,10) não foram diferentes em comparação com 
o grupo controle. A aceleração inicial da frequência cardíaca durante o 
exercício dinâmico (Δ = 12 ± 7,55 vs Δ = 19 ± 7,27, p = 0,01) também foi 
menor, mas a recuperação da frequência cardíaca, durante os primeiros 
dez segundos, foi maior no grupo sero-positivos [mediana:14 (intervalo 
Fig. 2 - Heart rate responses to dynamic exercise and serum levels of cardiac muscarinic auto-antibodies in sero-positive patients. The initial heart rate acceleration (A) did not correlate with the 
muscarinic auto-antibodies. On the contrary, the magnitude of heart rate deceleration at the cessation of exercise correlated directly with the serum levels of cardiac muscarinic auto-antibodies 
(B). (ΔI = Absolute increase in heart rate. ΔR = Absolute decrease in heart rate).  Patients subjects with abnormal EKG’s (Right bundle branch block),  Patients subjects with normal EKG`s. 
Optical density = milliunits of optic density (mU OD)
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interquartil: 9,75-17,50) vs 5 (0 - 8,75), p = 0,001]. Os níveis séricos 
de auto-anticorpos muscarínicos cardíacos foram significativamente 
maiores nos pacientes chagásicos do que no grupo controle [(mediana: 
34,58 densidade óptica (intervalo interquartil 17 - 46,5) vs (mediana: 0, 
intervalo interquartil 0 - 22,25) p = 0,001] e a correlação é significativa 
e direta (r = 0,68, p = 0,002) com o início da recuperação da frequência 
cardíaca durante o exercício dinâmico. Os resultados desta investigação 
sugerem que indiretamente, os auto-anticorpos muscarínicos cardíacos, 
podem ter ação agonista positiva sobre o controle parassimpático da 
frequência cardíaca dos pacientes chagásicos.
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